- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02727595
Evaluation of CyclaPlex Implant for Correction of First Inter Metatarsal Angle in Subjects Suffering From Hallux Valgus Deformity
March 30, 2016 updated by: Hillel Yaffe Medical Center
The purpose of the study is to evaluate safety, tolerability and performance of the CyclaPlex implant, a button and suture type implant device and instruments for the correction of the first inter metatarsal angle in subjects suffering from Hallux Valgus deformity.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rafi Herzog, BSc
- Email: rherzog@netvision.net.il
Study Locations
-
-
-
Hadera, Israel, 38100
- Hillel Yaffe Medical Center
-
Contact:
- Ori Hadash, MD
- Email: cafregel@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Weight less than 100 kilos
- IMA greater than 12 degrees
- IMA less than 7 degrees
Exclusion Criteria:
- Diabetics
- Known osteoporosis
- Known allergy or hypersensitivity to metals
- Gout or any systemic inflammatory arthropathy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CyclaPlex Implant
Implant device for reduction of the inter metatarsal angle (IMA) without osteotomy.
|
Button and suture type implant that will be implanted between the first and second metatarsal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IMA Reduction
Time Frame: One year
|
The IMA angle is measured pre-op and post-op on x-ray images using internal software.
The IMA at end of study should be less than 10 degrees or a reduction of more than 5 degrees.
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
American Orthopedic Foot and Ankle Society (AOFAS) Score
Time Frame: One year
|
General improvement as assessed by AOFAS Hallux Scale metatarsophalangeal interphalangeal scale score
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ori Hadash, MD, Hillel Yaffe Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Anticipated)
August 1, 2017
Study Completion (Anticipated)
September 1, 2017
Study Registration Dates
First Submitted
March 30, 2016
First Submitted That Met QC Criteria
March 30, 2016
First Posted (Estimate)
April 4, 2016
Study Record Updates
Last Update Posted (Estimate)
April 4, 2016
Last Update Submitted That Met QC Criteria
March 30, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HYMC-19-15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hallux Valgus
-
Arthrex GmbHTerminated
-
Catherine Vandepitte, M.D.Pacira Pharmaceuticals, IncCompleted
-
Dr.Gerhard KaufmannMedical University InnsbruckCompletedHallux Valgus and BunionAustria
-
Asklepieion Voulas General HospitalMaria Tileli; Chryssoula StaikouUnknown
-
Chinese University of Hong KongCompletedHallux Valgus | Hallux Valgus and BunionHong Kong
-
Hospital Mutua de TerrassaUnknownHallux Valgus and Bunion (Disorder)Spain
-
Fundación Universidad Católica de Valencia San...RecruitingHallux Valgus and BunionSpain
-
Dr.Gerhard KaufmannMedical University InnsbruckCompletedHallux Valgus | Hallux Valgus InterphalangeusAustria
-
Assiut UniversityNot yet recruitingHallux Valgus and Bunion
-
Cali Pharmaceuticals LLCCompletedHallux Valgus and BunionUnited States
Clinical Trials on CyclaPlex Implant
-
Meir Medical CenterUnknown
-
Aula Dental AvanzadaRecruiting
-
University of Sao PauloCompletedCataract | AstigmatismBrazil
-
Aula Dental AvanzadaCompleted
-
Mentor Worldwide, LLCWithdrawnAugmentation | Augmentation Revision | General Breast Enlargement | Post-lactational Involution | AsymmetryUnited States
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseUnited States
-
Ideal Implant IncorporatedCompletedBreast ImplantsUnited States
-
University of BernNot yet recruitingComplications | Patient Reported Outcome Measures | Cost-Benefit Analysis | Cost-effectiveness | Esthetic Zone | Single Tooth Dental Implant | Single Tooth Lost | Accuracy of Dental Implants | Dimensional Changes | Implant Survival and Success | Frequency of Treatment ProtocolSwitzerland
-
Cairo UniversityNot yet recruitingEdentulous; Alveolar Process, Atrophy
-
Cairo UniversityCompletedAtrophic Maxillary Ridge and Mandibular RidgeEgypt